Viewing Study NCT05636618

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 4:59 AM
Ignite Modification Date: 2026-01-26 @ 6:50 PM
Study NCT ID: NCT05636618
Status: RECRUITING
Last Update Posted: 2025-11-24
First Post: 2022-11-15
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Neuroendocrine Tumors
Sponsor: Perspective Therapeutics
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Neuroendocrine Tumors Unresectable View
None Neuroendocrine Tumor Metastatic View
None Gastroenteropancreatic Neuroendocrine Tumor View
None Bronchial Neuroendocrine Tumor View
None Paraganglioma View
None Pheochromocytoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Radiopharmaceuticals View
None Somatostatin Receptor Type 2 (SSTR2) View
None Neuroendocrine Tumors View
None Metastatic Neuroendocrine Tumors View
None Pb-212 View
None Theranostics View
None Alpha Particle Therapy View
None Radiotherapy View
None [212Pb]VMT-α-NET View
None VMT-α-NET-T01 View
None Pb-203 View